Brazilian descriptive study of 104 consecutive real-world migraine patients treated with monoclonal antibodies.

Abouch Valenty Krymchantowski Raimundo Pereira da Silva-Néto Carla JevouxAna Gabriela Krymchantowski

Published in: Postgraduate medicine (2022)

This described analysis of migraine patients who used monoclonal antibodies presented one of the first Brazilian experiences with real-world patients. Our results may enlighten clinicians on the outcomes and ways of prescribing anti-CGRP antibodies.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
primary care
palliative care
mental health
type diabetes
patient reported outcomes
metabolic syndrome
adipose tissue
skeletal muscle